OBJECTIVE: To determine whether magnetic resonance imaging measurements observed in the Alzheimer Disease Neuroimaging Initiative (ADNI) convenience sample differ from those observed in the Mayo Clinic Study of Aging (MCSA) population-based sample. DESIGN: Comparison of 2 samples. SETTING: Fifty-nine recruiting sites for the ADNI in the United States and Canada and the MCSA, a population-based cohort in Olmsted County, Minnesota. PATIENTS: Cognitively normal subjects and amnestic subjects with mild cognitive impairment were selected from the ADNI convenience cohort and MCSA population-based cohort. A simple random sample of subjects from both cohorts in the same age range was selected, and a second sample applied matching for age, sex, educational level, apolipoprotein E genotype, and Mini-Mental State Examination score. MAIN OUTCOME MEASURES: Baseline hippocampal volumes and annual percentage of decline in hippocampal volume. RESULTS: In the population-based sample, MCSA subjects were older, had less education, performed worse on the Mini-Mental State Examination, and had a family history of Alzheimer disease less often than did ADNI subjects. Baseline hippocampal volumes were larger in ADNI compared with MCSA cognitively normal subjects in the random sample, although no differences were observed after matching. Rates of decline in hippocampal volume were greater in the ADNI compared with the MCSA for cognitively normal subjects and those with amnestic mild cognitive impairment, even after matching. CONCLUSIONS:Rates of decline in hippocampal volume suggest that ADNI subjects have a more aggressive brain pathologic process than MCSA subjects and hence may not be representative of the general population. These findings have implications for treatment trials that use ADNI-like recruitment mechanisms and for studies validating new diagnostic criteria for Alzheimer disease in its various stages.
RCT Entities:
OBJECTIVE: To determine whether magnetic resonance imaging measurements observed in the Alzheimer Disease Neuroimaging Initiative (ADNI) convenience sample differ from those observed in the Mayo Clinic Study of Aging (MCSA) population-based sample. DESIGN: Comparison of 2 samples. SETTING: Fifty-nine recruiting sites for the ADNI in the United States and Canada and the MCSA, a population-based cohort in Olmsted County, Minnesota. PATIENTS: Cognitively normal subjects and amnestic subjects with mild cognitive impairment were selected from the ADNI convenience cohort and MCSA population-based cohort. A simple random sample of subjects from both cohorts in the same age range was selected, and a second sample applied matching for age, sex, educational level, apolipoprotein E genotype, and Mini-Mental State Examination score. MAIN OUTCOME MEASURES: Baseline hippocampal volumes and annual percentage of decline in hippocampal volume. RESULTS: In the population-based sample, MCSA subjects were older, had less education, performed worse on the Mini-Mental State Examination, and had a family history of Alzheimer disease less often than did ADNI subjects. Baseline hippocampal volumes were larger in ADNI compared with MCSA cognitively normal subjects in the random sample, although no differences were observed after matching. Rates of decline in hippocampal volume were greater in the ADNI compared with the MCSA for cognitively normal subjects and those with amnestic mild cognitive impairment, even after matching. CONCLUSIONS: Rates of decline in hippocampal volume suggest that ADNI subjects have a more aggressive brain pathologic process than MCSA subjects and hence may not be representative of the general population. These findings have implications for treatment trials that use ADNI-like recruitment mechanisms and for studies validating new diagnostic criteria for Alzheimer disease in its various stages.
Authors: C R Jack; M Slomkowski; S Gracon; T M Hoover; J P Felmlee; K Stewart; Y Xu; M Shiung; P C O'Brien; R Cha; D Knopman; R C Petersen Journal: Neurology Date: 2003-01-28 Impact factor: 9.910
Authors: R O Roberts; Y E Geda; D S Knopman; R H Cha; V S Pankratz; B F Boeve; E G Tangalos; R J Ivnik; W A Rocca; R C Petersen Journal: Neurology Date: 2012-01-25 Impact factor: 9.910
Authors: C R Jack; D W Dickson; J E Parisi; Y C Xu; R H Cha; P C O'Brien; S D Edland; G E Smith; B F Boeve; E G Tangalos; E Kokmen; R C Petersen Journal: Neurology Date: 2002-03-12 Impact factor: 9.910
Authors: R L Barnhart; G van Belle; S D Edland; W Kukull; S Borson; M Raskind; L Teri; P McLean; E Larson Journal: J Geriatr Psychiatry Neurol Date: 1995-10 Impact factor: 2.680
Authors: Jennifer L St Sauver; Brandon R Grossardt; Barbara P Yawn; L Joseph Melton; Joshua J Pankratz; Scott M Brue; Walter A Rocca Journal: Int J Epidemiol Date: 2012-11-18 Impact factor: 7.196
Authors: Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Jesse Cedarbaum; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Johan Luthman; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie Shaw; Li Shen; Adam Schwarz; Arthur W Toga; John Q Trojanowski Journal: Alzheimers Dement Date: 2015-06 Impact factor: 21.566
Authors: Ann Hake; Paula T Trzepacz; Shufang Wang; Peng Yu; Michael Case; Helen Hochstetler; Michael M Witte; Elisabeth K Degenhardt; Robert A Dean Journal: Alzheimers Dement Date: 2015-04-24 Impact factor: 21.566
Authors: Rachel L Nosheny; Philip S Insel; Diana Truran; Norbert Schuff; Clifford R Jack; Paul S Aisen; Leslie M Shaw; John Q Trojanowski; Michael W Weiner Journal: Neurobiol Aging Date: 2014-08-01 Impact factor: 4.673
Authors: Kamolika Roy; Lesley C Pepin; Marlie Philiossaint; Natacha Lorius; J Alex Becker; Joseph J Locascio; Dorene M Rentz; Reisa A Sperling; Keith A Johnson; Gad A Marshall Journal: J Alzheimers Dis Date: 2014 Impact factor: 4.472
Authors: Anisha Keshavan; Friedemann Paul; Mona K Beyer; Alyssa H Zhu; Nico Papinutto; Russell T Shinohara; William Stern; Michael Amann; Rohit Bakshi; Antje Bischof; Alessandro Carriero; Manuel Comabella; Jason C Crane; Sandra D'Alfonso; Philippe Demaerel; Benedicte Dubois; Massimo Filippi; Vinzenz Fleischer; Bertrand Fontaine; Laura Gaetano; An Goris; Christiane Graetz; Adriane Gröger; Sergiu Groppa; David A Hafler; Hanne F Harbo; Bernhard Hemmer; Kesshi Jordan; Ludwig Kappos; Gina Kirkish; Sara Llufriu; Stefano Magon; Filippo Martinelli-Boneschi; Jacob L McCauley; Xavier Montalban; Mark Mühlau; Daniel Pelletier; Pradip M Pattany; Margaret Pericak-Vance; Isabelle Cournu-Rebeix; Maria A Rocca; Alex Rovira; Regina Schlaeger; Albert Saiz; Till Sprenger; Alessandro Stecco; Bernard M J Uitdehaag; Pablo Villoslada; Mike P Wattjes; Howard Weiner; Jens Wuerfel; Claus Zimmer; Frauke Zipp; Stephen L Hauser; Jorge R Oksenberg; Roland G Henry Journal: Neuroimage Date: 2016-04-01 Impact factor: 6.556
Authors: Khader M Hasan; Benson Mwangi; Bo Cao; Zafer Keser; Nicholas J Tustison; Peter Kochunov; Richard E Frye; Mirjana Savatic; Jair Soares Journal: J Neuroimaging Date: 2015-10-08 Impact factor: 2.486